Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Truist cuts National Health Investors stock price target on asset sale By Investing.com - Investing.com India
Truist cuts National Health Investors stock price target on asset sale By Investing.comInvesting.com India
Allianz, Jio Financial Services ink 50:50 insurance JV to tap India’s growing market
Jio Financial Services and Allianz Group are partnering to launch a new insurance venture in India. This 50:50 joint venture will offer general and health insurance solutions. It combines Jio's digital reach with Allianz's global insurance expertise. The venture aims to expand insurance access for individuals and businesses. Operations will commence after regulatory approvals.
ET Women Conclave 2026 spotlights leadership, reinvention, and powerful conversations
The ET Women Conclave 2026 celebrated inspiring leaders, entrepreneurs, and changemakers with dialogues on authenticity, wellness, and impact. The event featured discussions on women scripting their success, staying true to themselves, and leading with confidence. It also highlighted advancements in women's health and the future of Indian craft-based fashion.
Biocon gains after Health Canada nod for cancer, osteoporosis drugs
Biocon shares rise after Health Canada approves Bosaya and Vevzuo denosumab biosimilars for osteoporosis and cancer bone conditions, stock up about 1.5 percent at 364.40
LIC’s bonus dhamaka sparks 7% rally in two days. What lies ahead?
LIC shares surged 7% in two sessions after announcing its first-ever 1:1 bonus issue, boosting investor sentiment. The move, involving capitalisation of Rs 6,325 crore reserves, signals strong financial health and may improve liquidity, though analysts remain watchful of long-term growth triggers and valuation trends.
Gaudium IVF and Women Health Limited Updates Corporate Identification Number Following Stock Exchange Listing - scanx.trade
Gaudium IVF and Women Health Limited Updates Corporate Identification Number Following Stock Exchange Listingscanx.trade
Muthoot Finance seeks shareholder nod for entry into insurance distribution biz
Muthoot Finance is gearing up for a pivotal growth phase as it seeks shareholder approval to venture into the insurance distribution arena. This bold step encompasses a wide range of offerings, including life, general, and health insurance products, marking the company's ambition to become a comprehensive corporate agent in India's insurance landscape.
Muthoot Finance plans entry into insurance distribution business
Muthoot Finance seeks shareholder approval to amend its charter and enter insurance distribution as a corporate agent across life, general and health segments in India
Retatrutide: Can this shot make you lose weight & live longer, too?
A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a potential breakthrough for diabetes and obesity. Experts believe it could also contribute to longevity goals. Clinical trials show significant weight loss. Retatrutide's unique triple-action mechanism sets it apart from existing treatments, promising a new era in metabolic health management.
Panacea Biotec bags Rs 20.79 crore LoA from Central Medical Services Society
Panacea Biotec announced that it has received a letter of award (LoA) worth Rs 20.79 crore from Central Medical Services Society, under the Ministry of Health and Family Welfare, Government of India.
Explained — Why Sun Pharma shares are down 5% in a strong market
Organon has a market capitalisation of $1.5 billion. The US company specializes in women's health. It spun off from Merck Sharp & Dohme in 2021.
Sun Pharma preps for $12-billion Organon bid in biggest overseas pharma M&A by Indian co
Sun Pharma is moving forward with a $12 billion offer for Organon & Co. This acquisition would be the largest for an Indian pharma company. Sun Pharma is finalizing financing for the deal. Organon specializes in women's health. The company is also facing competition from other global consortiums. This move signifies Sun Pharma's ambition to grow in innovative drug research.